Purchases and Sales Made in Q4 2021 in Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX) during Q4 2021. The information is specifically focused on institutions that hold shares of NEUROCRINE BIOSCIENCES INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2022
Q4 2021
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-470K- 54.4% |
$37.4M - $49.9M
|
394K
$46.9M
|
|
|
Feb 14, 2022
Q4 2021
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-502K- 79.73% |
$40M - $53.3M
|
128K
$15.2M
|
|
|
Feb 11, 2022
Q4 2021
|
Bank Of Montreal
Toronto, A6 |
SELL
|
- |
-636K- 85.17% |
$50.7M - $67.6M
|
111K
$13.2M
|
|
|
Feb 10, 2022
Q4 2021
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-938K- 69.52% |
$74.7M - $99.7M
|
411K
$49M
|
|
|
Feb 14, 2022
Q4 2021
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-1.54M- 17.14% |
$123M - $164M
|
7.45M
$887M
|